Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gretchen M Schroeder

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonistsGretchen M Schroeder, Donna Wei, Patrizia Banfi, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-ChainsEdgars Jecs, Eric J Miller, Robert J Wilson, et al.
Journal of Medicinal Chemistry|July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME PropertiesHuy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald CouplingsHuy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique PropertiesYesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Journal of Medicinal Chemistry|January 20, 2018
Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET PropertiesEric J Miller, Edgars Jecs, Valarie M Truax, et al.
Journal of Medicinal Chemistry|February 18, 2022
Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like ProfilesEdgars Jecs, Yesim A Tahirovic, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonistsGretchen M Schroeder, Donna Wei, Patrizia Banfi, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-ChainsEdgars Jecs, Eric J Miller, Robert J Wilson, et al.
Journal of Medicinal Chemistry|July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME PropertiesHuy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald CouplingsHuy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique PropertiesYesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Journal of Medicinal Chemistry|January 20, 2018
Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET PropertiesEric J Miller, Edgars Jecs, Valarie M Truax, et al.
Journal of Medicinal Chemistry|February 18, 2022
Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like ProfilesEdgars Jecs, Yesim A Tahirovic, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.
Pageof 3